Everest Group Ltd.

  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: BMG3223R1088
USD
313.71
-0.32 (-0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Everest Group Ltd. stock-summary
stock-summary
Everest Group Ltd.
Insurance
Everest Re Group, Ltd. through its subsidiaries, is engaged in the underwriting of reinsurance and insurance in the United States, Bermuda and international markets. The Company operates in segments: U.S. Reinsurance, International, Bermuda and Insurance. The Company underwrites reinsurance both through brokers and directly with ceding companies. The Company underwrites insurance principally through general agent relationships, brokers and surplus lines brokers. The Company offers treaty and facultative reinsurance, and admitted and non-admitted insurance. Its products include the range of property and casualty reinsurance, and insurance coverage's, including marine, aviation, surety, errors and omissions liability (E&O), directors' and officers' liability (D&O), medical malpractice, other specialty lines, accident and health (A&H) and workers' compensation. The Company's subsidiaries include Everest Reinsurance (Bermuda), Ltd. (Bermuda Re) and Everest International Reinsurance, Ltd.
Company Coordinates stock-summary
Company Details
Seon Place, 4Th Floor, 141 Front Street, 845, P.O. Box HM, HAMILTON None : HM 19
stock-summary
Tel: 1 441 29500061 908 6043169
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 140 Schemes (42.02%)

Foreign Institutions

Held by 338 Foreign Institutions (20.47%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Joseph Taranto
Chairman of the Board
Mr. Juan Andrade
President, Chief Executive Officer, Director
Mr. William Galtney
Lead Independent Director
Mr. John Amore
Independent Director
Mr. John Graf
Independent Director
Ms. Meryl Hartzband
Independent Director
Ms. Geraldine Losquadro
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
680 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 25,076 Million (Small Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

170.98%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

5.37%

stock-summary
Price to Book

1.67